CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group.
暂无分享,去创建一个
A. López-Guillermo | U. Jaeger | S. Kvaløy | M. Pfreundschuh | M. Loeffler | R. Stahel | P. Zinzani | L. Trümper | L. Shepherd | P. de Nully Brown | A. Osterborg | R. Pettengell | M. Trněný | D. Gill | J. Walewski | O. Shpilberg | N. Milpied | E. Kuhnt | V. Poeschel | N. Murawski | S. Grass